On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical ...

FDA approves Tavapadon for Parkinson’s Disease in adults, offering new hope for symptom management. Discover what this means ...

JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...

Dopamine agonists such as pramipexole, ropinirole, rotigotine, and apomorphine have long been recommended as initial therapy for younger patients with Parkinson’s disease, typically those younger than ...

Basic knowledge for "treating the whole body," not just motor symptomsWhen you hear Parkinson's disease, you might first think of "hand tremors" or "difficulty walking." However, the important point ...

A new study from Reichman University has found that a short, three-week digital training program, combined with standard drug treatment for Parkinson's disease, led to significant improvements in ...

BEND, Ore. (KTVZ) - Destination Rehab says it's proud to announce the ongoing success of its innovative Rock Climbing for Parkinson’s Disease program—an eight-week community fitness initiative ...

(A) The pipeline of the MIRT treatment and data collection. (B) The pipeline of the EEG microstate analysis. (C) The pipeline of the fMRI coactivation pattern calculation. EEG, electroencephalography; ...

BEND, Ore. (KTVZ) -- Destination Rehab says it is excited to announce the launch of its Walking Soccer for Parkinson’s program, a nine-week indoor program designed specifically for individuals living ...